Senegal’s Institut Pasteur of Dakar (IPD) has reached a deal with US company MedInstill for the bottling of COVID-19 vaccines, an EU document shows, marking a step to becoming a fully-fledged maker of vaccines against the novel coronavirus for Africa.
The EU is a major financial backer of the project, which aims to enable the institute to manufacture 300 million vaccine doses per year and reduce Africa’s reliance on imported vaccines.
However, the institute has yet to secure a partnership with a COVID-19 vaccine patent holder to produce doses.
African countries have so far received a tiny portion of COVID-19 shots produced globally, as wealthy nations have bought most of the output.
South Africa’s Aspen Pharmacare, which produces the Johnson & Johnson COVID-19 vaccine, is Africa’s only COVID-19 vaccine producer.
“IPD plans in a first phase to work on fill & finish and only later to carry out full production,” the internal EU document seen by Reuters said. “At the moment, partnerships have been signed with U.S. firm MedInstill for the fill & finish, and with Belgian company Univercells for the development of the active substance.”
The document was produced by the bloc’s diplomatic delegation in Dakar.
MedInstill declined to comment on the deal. IPD did not respond to a request for comment.
Backers of the project last month announced that a new plant in Senegal to manufacture COVID-19 vaccines would produce 25 million doses per month by the end of next year.
The EU document said that the plant is expected to begin production at the end of the second quarter of next year.
A decision on what type of COVID-19 vaccine would be produced has not yet been made, the document said, adding that a major risk for the project would be difficulties linked to the selection of the vaccine technology.
The document said that two options are being assessed more closely at the moment: a partnership with German drugmaker BioNTech for the production of its messenger ribonucleic acid (mRNA) COVID-19 vaccine, which was jointly developed with US firm Pfizer, or a new partnership deal with Univercells for the production of a viral vector COVID-19 vaccine that the Belgian firm is developing with Italy’s ReiThera.
Alternatively the institute might produce an mRNA COVID-19 vaccine that Univercells is trying to develop through its unit Quantoom Biosciences.
BioNTech declined to comment and Univercells did not respond to requests for comment.
The document said that “in theory,” other holders of COVID-19 vaccine patents could be interested in making their shots in Senegal, citing AstraZeneca and Johnson & Johnson.
Only vaccines that have already been approved by a major drugs regulator, such as the European Medicines Agency, or are prequalified by the WHO can be chosen for production in Senegal, the document said.
Univercells’ potential vaccines are still being trialed and have no authorization yet.
The institute is the only facility in West Africa currently producing a vaccine — a yellow fever shot — that is prequalified by the WHO, which requires manufacturers to meet strict international standards.
There are currently fewer than 10 African manufacturers that produce vaccines against any disease, in Egypt, Morocco, Senegal, South Africa and Tunisia.
The EU has said it wants to back the development of vaccine production hubs in at least three African countries, including Senegal and South Africa.
PARLIAMENT CHAOS: Police forcibly removed Brazilian Deputy Glauber Braga after he called the legislation part of a ‘coup offensive’ and occupied the speaker’s chair Brazil’s lower house of Congress early yesterday approved a bill that could slash former Brazilian president Jair Bolsonaro’s prison sentence for plotting a coup, after efforts by a lawmaker to disrupt the proceedings sparked chaos in parliament. Bolsonaro has been serving a 27-year term since last month after his conviction for a scheme to stop Brazilian President Luiz Inacio Lula da Silva from taking office after the 2022 election. Lawmakers had been discussing a bill that would significantly reduce sentences for several crimes, including attempting a coup d’etat — opening up the prospect that Bolsonaro, 70, could have his sentence cut to
A plan by Switzerland’s right-wing People’s Party to cap the population at 10 million has the backing of almost half the country, according to a poll before an expected vote next year. The party, which has long campaigned against immigration, argues that too-fast population growth is overwhelming housing, transport and public services. The level of support comes despite the government urging voters to reject it, warning that strict curbs would damage the economy and prosperity, as Swiss companies depend on foreign workers. The poll by newspaper group Tamedia/20 Minuten and released yesterday showed that 48 percent of the population plan to vote
A powerful magnitude 7.6 earthquake shook Japan’s northeast region late on Monday, prompting tsunami warnings and orders for residents to evacuate. A tsunami as high as three metres (10 feet) could hit Japan’s northeastern coast after an earthquake with an estimated magnitude of 7.6 occurred offshore at 11:15 p.m. (1415 GMT), the Japan Meteorological Agency (JMA) said. Tsunami warnings were issued for the prefectures of Hokkaido, Aomori and Iwate, and a tsunami of 40cm had been observed at Aomori’s Mutsu Ogawara and Hokkaido’s Urakawa ports before midnight, JMA said. The epicentre of the quake was 80 km (50 miles) off the coast of
Brazilian Senator Flavio Bolsonaro on Friday said that his father, jailed former Brazilian president Jair Bolsonaro, has chosen him to lead the country’s powerful conservative movement, shaking up next year’s election race. The 44-year-old senator said on social media that he will carry forward the political legacy that reshaped Brazilian politics. His announcement makes him an instant contender for the presidency. Jair Bolsonaro, 70, is unlikely to run after being sentenced to 27 years for plotting a coup and banned from public office. He is appealing and seeking a legislative pardon. The former president also faces serious health issues, including complications from a
RSS